Clinical Trial Update: Cadonilimab in Patients (Pts) with Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

Cadonilimab is being studied in a Phase 2 trial for advanced non-small cell lung cancer and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Cadonilimab

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Stage IVB Lung Cancer, Non-Squamous | Phase 2 | Status: RECRUITING